# Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy

> **NCT01543100** · NA · COMPLETED · sponsor: **Rennes University Hospital** · enrollment: 60 (actual)

## Conditions studied

- Monoclonal Gammopathy
- Monoclonal Gammopathy of Undetermined Signification
- Myeloma

## Interventions

- **OTHER:** blood and bone marrow samples

## Key facts

- **NCT ID:** NCT01543100
- **Lead sponsor:** Rennes University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2014-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01543100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01543100, "Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01543100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*